Postmenopausal hormone replacement therapy.
作者信息
Jacobs H S, Loeffler F E
机构信息
Middlesex Hospital, University College London Medical School.
出版信息
BMJ. 1992 Dec 5;305(6866):1403-8. doi: 10.1136/bmj.305.6866.1403.
Abstract
摘要
相似文献
1
Postmenopausal hormone replacement therapy.绝经后激素替代疗法
BMJ. 1992 Dec 5;305(6866):1403-8. doi: 10.1136/bmj.305.6866.1403.
2
Recent studies bring risks, benefits of hormone replacement therapy under scrutiny.近期研究对激素替代疗法的风险与益处进行了审视。
J Natl Cancer Inst. 2001 Sep 5;93(17):1287-8. doi: 10.1093/jnci/93.17.1287.
3
Benefits and drawbacks to hormone replacement therapy among nursing home patients.疗养院患者激素替代疗法的利弊
Womens Health Issues. 1998 Jan-Feb;8(1):53-9. doi: 10.1016/s1049-3867(97)00094-7.
4
Hormone replacement therapy. Clinical synthesis panel on HRT.激素替代疗法。激素替代疗法临床综合小组。
J Epidemiol Biostat. 1999;4(3):123-8.
5
Hormone replacement therapy. Comments from the editor.
Br Med Bull. 1992 Apr;48(2):469-71. doi: 10.1093/oxfordjournals.bmb.a072556.
6
7
Decision factors influencing hormone replacement therapy.影响激素替代疗法的决策因素。
Br J Obstet Gynaecol. 1996 May;103 Suppl 13:92-7; discussion 97-8.
8
Hormone replacement therapy: some answers ... more questions.激素替代疗法：一些答案……更多问题。
J Natl Cancer Inst. 1992 Mar 18;84(6):389-90. doi: 10.1093/jnci/84.6.389.
9
Clinical practice. Postmenopausal hormone-replacement therapy.临床实践。绝经后激素替代疗法。
N Engl J Med. 2001 Jul 5;345(1):34-40. doi: 10.1056/NEJM200107053450106.
10
Hormone replacement therapy: boon or bane?激素替代疗法：福还是祸？
Can J Surg. 1995 Oct;38(5):409-14.
引用本文的文献
1
Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.西澳大利亚州子宫切除术后激素替代疗法使用者的健康状况。
J Epidemiol Community Health. 2003 Apr;57(4):294-300. doi: 10.1136/jech.57.4.294.
2
The male menopause: does it exist?: against: problems of senescence in men are not analogous to female menopause.男性更年期：它存在吗？反对观点：男性衰老问题与女性更年期并不相似。
West J Med. 2000 Aug;173(2):78-9. doi: 10.1136/ewjm.173.2.78.
3
For and against: The male menopause--does it exist?支持与反对：男性更年期——它存在吗？
BMJ. 2000 Mar 25;320(7238):858-61. doi: 10.1136/bmj.320.7238.858.
4
Prevention and treatment of postmenopausal osteoporosis.
Pharm World Sci. 1998 Oct;20(5):198-205. doi: 10.1023/a:1008682921480.
5
Prescribing patterns for nursing home residents in the US. The reality and the vision.美国疗养院居民的用药模式。现实与展望。
Drugs Aging. 1997 Oct;11(4):255-60. doi: 10.2165/00002512-199711040-00001.
6
Drug-induced disorders of glucose metabolism. Mechanisms and management.药物诱导的糖代谢紊乱。机制与管理。
Drug Saf. 1996 Aug;15(2):135-57. doi: 10.2165/00002018-199615020-00005.
7
Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments.
Osteoporos Int. 1996;6(4):265-75. doi: 10.1007/BF01623384.
8
Hormone replacement therapy for all? Not for everybody.所有人都适合激素替代疗法吗？并非如此。
BMJ. 1996 Aug 10;313(7053):351-2. doi: 10.1136/bmj.313.7053.351.
9
Hormone replacement therapy in the aged. A state of the art review.
Drugs Aging. 1996 Mar;8(3):193-213. doi: 10.2165/00002512-199608030-00005.
10
Postmenopausal hormone replacement therapy.绝经后激素替代疗法
BMJ. 1993 Jan 23;306(6872):270. doi: 10.1136/bmj.306.6872.270-a.
本文引用的文献
1
Endometrial disease after treatment with oestrogens and progestogens in the climacteric.更年期使用雌激素和孕激素治疗后的子宫内膜疾病
Br Med J. 1980 Mar 22;280(6217):822-4. doi: 10.1136/bmj.280.6217.822.
2
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.合成类固醇（Org OD 14）预防绝经后骨质疏松症的前瞻性双盲试验。
Br Med J. 1980 May 17;280(6225):1207-9. doi: 10.1136/bmj.280.6225.1207.
3
A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects.一种用于人体髂嵴骨活检的光镜与扫描电镜关联的简单方法：正常及骨质疏松受试者的定性观察
J Bone Miner Res. 1986 Feb;1(1):15-21. doi: 10.1002/jbmr.5650010105.
4
Evidence of estrogen receptors in normal human osteoblast-like cells.正常人成骨样细胞中雌激素受体的证据。
Science. 1988 Jul 1;241(4861):84-6. doi: 10.1126/science.3388021.
5
Postmenopausal use of estrogen and occlusion of coronary arteries.绝经后使用雌激素与冠状动脉阻塞
Am Heart J. 1988 May;115(5):954-63. doi: 10.1016/0002-8703(88)90063-4.
6
Oestrogen therapy after the menopause--boon or bane?绝经后雌激素治疗——福还是祸？
Med J Aust. 1988 Mar 7;148(5):213-4. doi: 10.5694/j.1326-5377.1988.tb99424.x.
7
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.雌激素和孕激素在乳腺癌流行病学及预防中的作用。
Eur J Cancer Clin Oncol. 1988 Jan;24(1):29-43. doi: 10.1016/0277-5379(88)90173-3.
8
Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles.
Biochem Biophys Res Commun. 1987 Jan 15;142(1):63-9. doi: 10.1016/0006-291x(87)90451-7.
9
Risk factors and noncontraceptive estrogen use in women with and without coronary disease.患有和未患有冠心病的女性的风险因素及非避孕雌激素的使用情况。
Am Heart J. 1989 Jun;117(6):1209-14. doi: 10.1016/0002-8703(89)90398-0.
10
Hormone replacement therapy in women treated for breast cancer.乳腺癌女性患者的激素替代疗法。
Eur J Cancer Clin Oncol. 1989 Dec;25(12):1909-13. doi: 10.1016/0277-5379(89)90372-6.
Zotero 插件